Lipocine CEO Mahesh V. Patel reports acquisition of 50,000 common shares for $79,487.50
LPCN•Lipocine CEO and director Mahesh V. Patel purchased 50,000 common shares for $79,487.50, increasing his direct holdings to 211,495 shares.
1. Share purchases
Patel bought 25,000 shares at $1.5796 each and another 25,000 at $1.5999 each, bringing his direct holdings to 211,495 shares.
